Literature DB >> 3471868

Cerebellar sclerosis in pediatric cancer patients.

M Wizniter, R J Packer, L B Rorke, A T Meadows.   

Abstract

Cerebral cortical sclerosis is an acquired condition that has rarely been described in cancer patients. We reviewed necropsy findings in all children with cancer who died at the Children's Hospital of Philadelphia during the 20 year period 1963-1982 and found cerebellar sclerosis in 14 children with cancer (12 with acute lymphoblastic leukemia, 1 each with neuroblastoma and osteogenic sarcoma). The lesions were focal (3), multifocal (9) or diffuse (2). They occurred more frequently in children with acute lymphoblastic leukemia who had received intravenous methotrexate therapy. Ten of these 12 children had also received whole brain irradiation. The pathogenesis of the cerebellar sclerosis is unknown, but it is possible that extrinsic cerebellar compression by tumor or chronically increased intracranial pressure may have played a role in 6, ischemia/hypoxia in 3, and methotrexate toxicity in 2. No clear associations could be ascertained in 3. Methotrexate may be a previously unrecognized cause of cerebellar cortical injury. In addition, oncologic treatment regimens that include other central nervous system-penetrating drugs and irradiation may sensitize cerebellar cortex and make it more susceptible to other cerebellar sclerosis-causative factors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3471868     DOI: 10.1007/BF00195606

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  23 in total

1.  The central nervous system in acute leukemia: a postmortem study of 117 consecutive cases, with particular reference to hemorrhages, leukemic infiltrations, and the syndrome of meningeal leukemia.

Authors:  E W MOORE; L B THOMAS; R K SHAW; E J FREIREICH
Journal:  Arch Intern Med       Date:  1960-03

2.  Infiltration of the leptomeninges by systemic cancer. A clinical and pathologic study.

Authors:  M E Olson; N L Chernik; J B Posner
Journal:  Arch Neurol       Date:  1974-02

3.  Proceedings: Parenchymatous degeneration of the central nervous system in childhood leukemia.

Authors:  B Hendin; D C DeVivo; R Torack; M E Lell; A H Ragab; T J Vietti
Journal:  Cancer       Date:  1974-02       Impact factor: 6.860

4.  The central nervous system in childhood leukemia. I. The arachnoid.

Authors:  R A Price; W W Johnson
Journal:  Cancer       Date:  1973-03       Impact factor: 6.860

5.  Leukoencephalopathy following the administration of methotrexate into the cerebrospinal fluid in the treatment of primary brain tumors.

Authors:  H Norrell; C B Wilson; D E Slagel; D B Clark
Journal:  Cancer       Date:  1974-04       Impact factor: 6.860

6.  Necrotizing encephalopathy following intraventricular instillation of methotrexate.

Authors:  W R Shapiro; N L Chernik; J B Posner
Journal:  Arch Neurol       Date:  1973-02

7.  Sclerotic atrophy of the cerebellum: a clinicopathological survey.

Authors:  N P Rosman; M B Schapiro; P A Wolf
Journal:  J Neuropathol Exp Neurol       Date:  1978 Mar-Apr       Impact factor: 3.685

8.  Acute cerebellar dysfunction with high-dose ARA-C therapy.

Authors:  M C Salinsky; R L Levine; J P Aubuchon; H S Schutta
Journal:  Cancer       Date:  1983-02-01       Impact factor: 6.860

9.  Central nervous system toxicity of high-dose cytosine arabinoside.

Authors:  L Grossman; M A Baker; D M Sutton; J H Deck
Journal:  Med Pediatr Oncol       Date:  1983

10.  Leukoencephalopathy in childhood leukemia.

Authors:  D C Devivo; D Malas; J S Nelson; V J Land
Journal:  Neurology       Date:  1977-07       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.